ARNA - Arena Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.57B
Enterprise Value 31.06B
Trailing P/E N/A
Forward P/E 1-12.08
PEG Ratio (5 yr expected) 10.69
Price/Sales (ttm)73.40
Price/Book (mrq)7.54
Enterprise Value/Revenue 349.50
Enterprise Value/EBITDA 6-13.95

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin 0.00%
Operating Margin (ttm)-374.90%

Management Effectiveness

Return on Assets (ttm)-19.67%
Return on Equity (ttm)-77.45%

Income Statement

Revenue (ttm)21.34M
Revenue Per Share (ttm)0.65
Quarterly Revenue Growth (yoy)-82.00%
Gross Profit (ttm)108.63M
EBITDA -75.71M
Net Income Avi to Common (ttm)-94.53M
Diluted EPS (ttm)-2.77
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)247.08M
Total Cash Per Share (mrq)6.27
Total Debt (mrq)61.75M
Total Debt/Equity (mrq)29.81
Current Ratio (mrq)3.89
Book Value Per Share (mrq)5.27

Cash Flow Statement

Operating Cash Flow (ttm)-66.64M
Levered Free Cash Flow (ttm)-38.6M

Trading Information

Stock Price History

Beta 2.60
52-Week Change 3116.01%
S&P500 52-Week Change 315.52%
52 Week High 344.50
52 Week Low 311.30
50-Day Moving Average 339.25
200-Day Moving Average 331.83

Share Statistics

Avg Vol (3 month) 3679.87k
Avg Vol (10 day) 31.5M
Shares Outstanding 539.4M
Float 39.3M
% Held by Insiders 10.27%
% Held by Institutions 174.32%
Shares Short 32.77M
Short Ratio 35.53
Short % of Float 311.21%
Shares Short (prior month) 32.68M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/10
Last Split Date 3Jun 19, 2017